Fluxion Biosciences, Inc., a pioneering force in the biotechnology sector, is headquartered in the United States. Founded in 2006, the company has established itself as a leader in the development of advanced microfluidic systems for life sciences research and diagnostics. With a focus on single-cell analysis and high-throughput screening, Fluxion's innovative platforms enable researchers to gain deeper insights into cellular behaviour and disease mechanisms. The company’s flagship products, including the IsoFlux System and the BioFlux platform, are distinguished by their ability to provide precise, real-time data, setting them apart in a competitive market. Fluxion's commitment to advancing scientific discovery has garnered recognition within the industry, positioning it as a trusted partner for academic and commercial laboratories alike. With a strong emphasis on innovation and quality, Fluxion Biosciences continues to drive progress in the fields of genomics and personalised medicine.
We don't have data for Fluxion Biosciences, Inc., but we can show you information about their parent organization instead.
View parent company